These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35753742)

  • 41. Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma.
    Jiang T; Lyu SC; Zhou L; Wang J; Li H; He Q; Lang R
    World J Gastrointest Surg; 2021 Sep; 13(9):1025-1038. PubMed ID: 34621478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer.
    Zhang K; Hua YQ; Wang D; Chen LY; Wu CJ; Chen Z; Liu LM; Chen H
    J Transl Med; 2019 Jan; 17(1):30. PubMed ID: 30658662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma.
    Loosen SH; Roderburg C; Kauertz KL; Pombeiro I; Leyh C; Benz F; Vucur M; Longerich T; Koch A; Braunschweig T; Ulmer TF; Heidenhain C; Tacke F; Binnebösel M; Schmeding M; Trautwein C; Neumann UP; Luedde T
    J Hepatol; 2017 Oct; 67(4):749-757. PubMed ID: 28668580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis.
    Chen LX; Zou SJ; Li D; Zhou JY; Cheng ZT; Zhao J; Zhu YL; Kuang D; Zhu XH
    World J Gastroenterol; 2020 Dec; 26(48):7664-7678. PubMed ID: 33505143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic Cholangiocarcinoma.
    Zhu Y; Zhu Y; Cai F; Zhao J; Liu F
    Cell Biochem Biophys; 2015 Nov; 73(2):455-460. PubMed ID: 27352338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification.
    Yen CC; Yen CJ; Shan YS; Lin YJ; Liu IT; Huang HY; Yeh MM; Chan SH; Tsai HW
    Histopathology; 2021 Oct; 79(4):556-572. PubMed ID: 33837585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis.
    Lin PC; Lin JK; Lin CC; Wang HS; Yang SH; Jiang JK; Lan YT; Lin TC; Li AF; Chen WS; Chang SC
    Int J Colorectal Dis; 2012 Oct; 27(10):1333-8. PubMed ID: 22426691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The value of NLR, FIB, CEA and CA19-9 in colorectal cancer].
    Qian X; Wang H; Ren Z; Jin F; Pan SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Apr; 55(4):499-505. PubMed ID: 33858062
    [No Abstract]   [Full Text] [Related]  

  • 49. Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland.
    Barner-Rasmussen N; Pukkala E; Hadkhale K; Färkkilä M
    United European Gastroenterol J; 2021 Dec; 9(10):1128-1135. PubMed ID: 34533900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression levels of serum miRNA-195 in different types of patients with cholangiocarcinoma and its value to determine the prognosis thereof.
    Chen Q; Wang C; Zhang H; Li Y; Cao Y; Zhang Y; Liu S; Li Z; Xin X; Han X
    Oncol Lett; 2018 Apr; 15(4):5947-5951. PubMed ID: 29552225
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trends in Incidence and Factors Affecting Survival of Patients With Cholangiocarcinoma in the United States.
    Mukkamalla SKR; Naseri HM; Kim BM; Katz SC; Armenio VA
    J Natl Compr Canc Netw; 2018 Apr; 16(4):370-376. PubMed ID: 29632056
    [No Abstract]   [Full Text] [Related]  

  • 52. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
    Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
    J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
    [No Abstract]   [Full Text] [Related]  

  • 53. Prognostic significance of neutrophil-lymphocyte ratio and carbohydrate antigen 19-9 in patients with gallbladder carcinoma.
    Liu F; Hu HJ; Ma WJ; Yang Q; Wang JK; Li FY
    Medicine (Baltimore); 2019 Feb; 98(8):e14550. PubMed ID: 30813165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical features and prognostic factors for liver cancer from a referral center in northern Thailand.
    Leerapun A; Thaikruea L; Pisespongsa P; Chitapanarux T; Praisontarangkul OA; Thongsawat S
    J Med Assoc Thai; 2013 May; 96(5):531-7. PubMed ID: 23745306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival of cholangiocarcinoma patients in northeastern Thailand after supportive treatment.
    Thunyaharn N; Promthet S; Wiangnon S; Suwanrungruang K; Kamsa-ard S
    Asian Pac J Cancer Prev; 2013; 14(11):7029-32. PubMed ID: 24377644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High Expression of P38α and Preoperative Carbohydrate Antigen 19-9 Indicate Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma.
    Chen J; Zhao T; Jia S; Zhou S; Zhou L; Wang S; Ding G; Jiang G; Cao L
    J Cancer; 2018; 9(4):650-659. PubMed ID: 29556322
    [No Abstract]   [Full Text] [Related]  

  • 57. [The combination of YAP/TAZ predicts the clinical prognosis in patients with cholangiocarcinoma after radical resection].
    Liu Y; Wu Y; Ouyang YS; He JJ; Shen LL; Qi H; Cao F; Chen SG
    Zhonghua Nei Ke Za Zhi; 2021 Jul; 60(7):637-643. PubMed ID: 34619841
    [No Abstract]   [Full Text] [Related]  

  • 58. Prognostic Value of Changes in Preoperative and Postoperative Serum CA19-9 Levels in Gastric Cancer.
    Song XH; Liu K; Yang SJ; Zhang WH; Chen XL; Zhao LY; Chen XZ; Yang K; Zhou ZG; Hu JK
    Front Oncol; 2020; 10():1432. PubMed ID: 33014781
    [No Abstract]   [Full Text] [Related]  

  • 59. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma.
    Cai WK; Lin JJ; He GH; Wang H; Lu JH; Yang GS
    Int J Clin Exp Pathol; 2014; 7(11):7890-8. PubMed ID: 25550829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.